Think of Xultophy as Similar to Soliqua for Type 2 Diabetes

You'll see the new injectable, Xultophy, for type 2 diabetes.

Xultophy (ZUL-toh-fye) combines the long-acting "basal" insulin, Tresiba (insulin degludec) and the GLP-1 agonist, Victoza (liraglutide).

Think of Xultophy as similar to Soliqua, which is a combo of Lantus (insulin glargine) and Adlyxin (lixisenatide).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote